Jianming Wu

发表

Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells

J. Modiano, P. Moore, Robert Hullsiek, 2022, Frontiers in Immunology.

Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth

A. LeBeau, G. Hart, Robert Hullsiek, 2021, Cancer Immunology Research.

Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy

Jianming Wu, B. Walcheck, H. Mishra, 2019, Journal of leukocyte biology.

iNK-CD64/16A cells: a promising approach for ADCC?

Jianming Wu, B. Walcheck, 2019, Expert opinion on biological therapy.

Pluripotent stem cell-derived NK cells with high-affinity non-cleavable CD16a mediate improved anti-tumor activity.

Paul C. Rogers, D. Kaufman, Jeffrey S. Miller, 2019, Blood.

Identification of an ADAM17 Cleavage Region in Human CD16 (FcγRIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells

D. Kaufman, L. Higgins, Todd W. Markowski, 2015, PloS one.

ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils.

R. Newton, Yue Wang, Jianming Wu, 2013, Biochimica et biophysica acta.

Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells

D. Kaufman, Yunfang Li, Robert Hullsiek, 2018, bioRxiv.

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry

Fang Li, L. Du, J. Shang, 2019, Journal of Virology.

Genetic Mechanism of Human Neutrophil Antigen 2 Deficiency and Expression Variations

Yunfang Li, Ling Li, Jianming Wu, 2015, PLoS genetics.

An accurate genetic assay to identify human neutrophil antigen 2 deficiency

Yunfang Li, Jianming Wu, R. Schuller, 2022, Transfusion medicine.

The nonconservative CD177 single‐nucleotide polymorphism c.1291G>A is a genetic determinant for human neutrophil antigen‐2 atypical/low expression and deficiency

Yunfang Li, G. Bein, Ling Li, 2019, Transfusion.

Ablation of SYK kinase from primary human Natural Killer cells via CRISPR/Cas9 enhances cytotoxicity and cytokine production

Beau R. Webber, B. Moriarity, G. Hart, 2022, bioRxiv.

FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis

W. Guan, M. Bhargava, Yunfang Li, 2016, Human Genetics.

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells

Jianming Wu, B. Walcheck, Kate J. Dixon, 2021, Cancers.

Engineered iPSC-Derived NK Cells Expressing Recombinant CD64 for Enhanced ADCC

Paul C. Rogers, Jeffrey S. Miller, Bahram Valamehr, 2020 .

Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity.

H. Dolstra, Jianming Wu, P. D. de Jonge, 2023, Cytotherapy.

CD177 is a novel IgG Fc receptor and CD177 genetic variants affect IgG-mediated function

Jianming Wu, Yunfang Li, 2024, Frontiers in immunology.

iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma

Bahram Valamehr, Z. Davis, Robert Hullsiek, 2024, Frontiers in immunology.

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

Robert Hullsiek, Jianming Wu, M. Felices, 2024, Journal for immunotherapy of cancer.

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

Robert Hullsiek, Jianming Wu, M. Felices, 2024, bioRxiv.

iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting

Bahram Valamehr, Z. Davis, Jianming Wu, 2023, Journal for ImmunoTherapy of Cancer.